Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Emergen Research Logo The global Generic Drug Market size was USD 360.84 Billion in 2022 and is expected to register a rapid revenue CAGR o ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...

What's considered excellent revenue growth depends on the industry. With that context in mind, consider that Eli Lilly's ...

Eli Lilly's latest clinical readout for dual GIP/GLP-1 agonist tirzepatide is a big one, with data suggesting the drug can reduce the risk of developing type 2 diabetes in overweight and obese ...

Compounders had been allowed to produce and sell hundreds of thousands of their own versions of popular anti-obesity drugs, ...

Novo Nordisk will slash the price of its blockbuster weight-loss drug Wegovy for cash-paying patients, after American rival ...

Judy Kurtz chats with The Hill’s congressional reporter Mychael Schnell about President Trump saying he wants to “help” Mexico and Canada with his delay of some tariffs against Canada and Mexico until ...

Diabetes is one of the most common health conditions ... Mounjaro, manufactured by Lilly, may have emerged as the newest and most effective treatment option after a victory over Novo Nordisk ...

Feb. 28, 2025 — A study has provided new insights into the role of the brain as a crucial control center and the origin of obesity and type 2 diabetes. The hormone insulin plays a key role in ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...